Driving Innovation in Oncology and Beyond
Reading Time: 3 minutes San Francisco, United States: Novotech, the global full-service clinical Contract Research Organization (CRO), has published its latest whitepaper, offering in-depth analysis and emerging trends and advancements within the rapidly evolving field of cell and gene therapies. The report provides critical insights
Bulletin from the Extraordinary General Meeting of Metacon AB (publ)
Reading Time: 3 minutes Metacon AB (publ), corporate identity number 556724-1616 (the “Company”), has held an Extraordinary General Meeting today, 15 November 2024 at 10:00 CET, at Advokatfirman Schjødt, Hamngatan 27, Stockholm. The Extraordinary General Meeting made the following resolutions. Amendments of the articles of
Andersen Global Adds M&A Capabilities in New Zealand Through Collaboration with Three Sixty Capital Partners
Reading Time: 2 minutes San Francisco, United States: Andersen Global strengthens its platform in New Zealand through a Collaboration Agreement with Three Sixty Capital Partners, a strategic M&A advisory firm based in Auckland. Founded in 2012, Three Sixty Capital Partners is a
Lehto Group Plc, inside information: Information about Lehto’s energy construction business and the company’s intention to apply for the transfer of share trading to the First North Growth Market
Reading Time: 4 minutes Lehto Group PlcInsider information15 November 2024 at 11.00 (Finnish time) Lehto Group Oyj (“Lehto” or “Company”) has previously announced on 29 May 2024 that it will focus its business on real estate energy solutions and electricity storages (“Energy construction business”). The
EQL Pharma’s CBDO increases his holding in the company
Reading Time: 2 minutes EQL Pharma’s Chief Business Development Officer (CBDO), Carl Lindgren, increases his shareholding in the company. On November 14th, Carl Lindgren has bought 10,000 shares in the Company at an average price of SEK 60.00, a transaction totalling SEK 600,000. The trades were
Well-executed clinical introduction of EndoDrill[®] GI at Sahlgrenska University Hospital in Sweden
Reading Time: 2 minutes The cancer diagnostics company BiBBInstruments AB (“BiBB” and the “Company”), the developer of EndoDrill®, the world’s first market-cleared electric-driven biopsy instrument for endoscopy, announces that the first clinical tissue sampling procedures with EndoDrill® GI at Sahlgrenska University Hospital in Gothenburg have been successfully
Respiratorius CEO to BioStock: “We continue to reduce risk in the project”
Reading Time: < 1 minute Fri, Nov 15, 2024 08:15 CET Report this content The partnering process continues for Respiratorius, which recently released the report for the third quarter. The US patent has been approved and the focus is now on refining the
Lubrizol and Polyhose Sign MoU to Manufacture Medical Tubing, Expand Capacity in Chennai
Reading Time: 4 minutes Chennai, Tamil Nadu, India: Supported by the Government of Tamil Nadu, the MoU enables localisation of life-saving medical tubing The agreement includes the development of a new manufacturing facility, which will enable a five-fold capacity expansion of Lubrizol’s medical
SoundHound AI Delivers “Hey Kia” Voice AI Experience To India As Part of Kia Connect
Reading Time: 3 minutes Santa Clara, Calif., United States: SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice artificial intelligence, today announced the expansion of its advanced voice AI technology to Kia vehicles in India, with the integration of Hindi as a featured language.
Tokmanni Group’s Business Review for January–September 2024: Revenue increased and EBIT improved in the third quarter
Reading Time: 23 minutes Tokmanni Group Corporation Business Review Unaudited 15 November 2024 at 8:00 THIRD QUARTER 2024 HIGHLIGHTS Tokmanni Group’s revenue grew by 14.3% (23.6%) and was EUR 416.3 million (364.3) Like-for-like revenue increased by 0.8% (0.3%) Comparable gross profit was EUR 148.3 million